| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/07/2004 | WO2004015060A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 10/07/2004 | WO2004013303A3 Modified annexin proteins and methods for treating vaso-occlusive sickle-cell disease |
| 10/07/2004 | WO2004013297A3 Manzamine-producing actinomycetes |
| 10/07/2004 | WO2004013279A3 Helix-hairpin-helix motifs to manipulate properties of dna processing enzymes |
| 10/07/2004 | WO2004011597A3 Primary nucleotide sequence of the agrotis segetum granulosis viris (asgv), its use in a system to dicover insecticides, and use in prevention and control of agrotis segetum insect pest |
| 10/07/2004 | WO2004007709A3 Production of polyketides |
| 10/07/2004 | WO2004007678B1 Codon optimized synthetic plasmids |
| 10/07/2004 | WO2004007674A3 Neuronal and retinal gene expression patterns |
| 10/07/2004 | WO2004007666A3 Steroidogenic factor-1 protein variants and methods of making same |
| 10/07/2004 | WO2004002418A3 Compositions and methods comprising protein activated receptor antagonists |
| 10/07/2004 | WO2003106648A3 Compositions and methods relating to breast specific genes and proteins |
| 10/07/2004 | WO2003106633A3 Method to increase isoflavonoid levels in plants and plants producing increased levels of isoflavonoids |
| 10/07/2004 | WO2003101386A3 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 10/07/2004 | WO2003091415A3 Fluorobodies and chromobodies: binding ligands with intrinsic fluorescence and color |
| 10/07/2004 | WO2003083059A3 Mcp-1 mutant proteins, antibodies, compositions, methods and uses |
| 10/07/2004 | WO2003080795A3 Novel nucleic acids and secreted polypeptides |
| 10/07/2004 | WO2003076463A8 Listeria monocytogenes ctsr mutants presenting low virulence and stress-resistance |
| 10/07/2004 | WO2003072603A9 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours |
| 10/07/2004 | WO2003070981A8 Seequences specifically deleted mycobacterium tuberculosis genome and their use in diagnostics and as vaccines |
| 10/07/2004 | WO2003070768A3 Cd40 splice variants,method of detection thereof, compositions comprising said variant(s) or nucleic acid encoding the same and use thereof |
| 10/07/2004 | WO2003066893A8 Methods for specific rapid detection of pathogenic food-relevant bacteria |
| 10/07/2004 | WO2003066818A3 Secretion, transcription and sporulation genes in bacillus clausii |
| 10/07/2004 | WO2003062453A3 Polycystic kidney disease nucleic acids and proteins |
| 10/07/2004 | WO2003057725A3 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 10/07/2004 | WO2003033662A3 Protection against oxidative stress and inflammation by a cytoprotective response element |
| 10/07/2004 | WO2002100250A8 Wit 3.0, a novel gene to control soft tissue wound healing |
| 10/07/2004 | WO2002092000A3 Hbm variants that modulate bone mass and lipid levels |
| 10/07/2004 | WO2002078636A3 Detection and treatment of colorectal cancer |
| 10/07/2004 | WO2002070647A3 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses |
| 10/07/2004 | WO2002068451A3 Sperm protein 17 for the diagnosis and treatment of cancer |
| 10/07/2004 | WO2002060920A3 Prion isomers, methods of making, methods of using, and compositions and products comprising prion isomers |
| 10/07/2004 | US20040199946 Protein kinase stress-related proteins and methods of use in plants |
| 10/07/2004 | US20040199944 Comprises fusion protein coding optimized transit peptide for use in the generation of herbicide resistant plants; tissue engineering |
| 10/07/2004 | US20040199940 Comprises nuclelotide sequences coding protein which modulates ergosterol biosynthesis for use as tool in transformation, expression and biosynthesis of steroids in plants; tissue engineering |
| 10/07/2004 | US20040199939 Modified cry3a toxins and nucleic acid sequences coding therefor |
| 10/07/2004 | US20040199934 Transgenic rodents as animal moldels for modulation of b1 bradykinin receptor protein |
| 10/07/2004 | US20040198970 Maxp1 |
| 10/07/2004 | US20040198969 Compositions and methods for the diagnosis and treatment of tumor |
| 10/07/2004 | US20040198961 Fce fusion proteins for treatment of allergy and asthma |
| 10/07/2004 | US20040198956 Method for the preparation of gliadin-and glutenin-rich fractions out of gluten in an aqueous medium and in the presence of an acid |
| 10/07/2004 | US20040198955 Mammalian cytokines; related reagents |
| 10/07/2004 | US20040198954 Gram negagtive bacterial polypeptide for use in diagnosis, prevention and treatment of swine respiratory system infection disorders; veterinary medicine; vaccine development |
| 10/07/2004 | US20040198952 Polyclonal and monoclonal antibodies for use in bioassay for detection of immunosuppressants or imnnunosuppressant peptides |
| 10/07/2004 | US20040198951 Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof |
| 10/07/2004 | US20040198949 Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 10/07/2004 | US20040198688 for treatment of atopic conditions (dermatitis, allergies); point mutations |
| 10/07/2004 | US20040198686 Administering resistin-like molecules alpha or beta |
| 10/07/2004 | US20040198681 Administering to human or animal at least one polypeptide or a nucleic acid sequence encoding said polypeptide; protein design or protein engineering in the production of polypeptides allowing delivery of food essential amino acids for milk production in cows, farm animal production or human food |
| 10/07/2004 | US20040198679 Use of inhibitors of expression or activity of p8/com1 for treating tumors |
| 10/07/2004 | US20040198662 a 15 to 22-residue polypeptide analog that forms an amphipathic alpha helix in the presence of lipids; anticholesterol agents; hypercholesterolemia, cardiovascular disorders, atherosclerosis, restenosis, hypertriglyceridemia, high density lipoprotein deficiency, metabolic disorders |
| 10/07/2004 | US20040198658 Stanniocalcin polynucleotides, polypeptides and methods based thereon |
| 10/07/2004 | US20040198657 Prostate-specific membrane antigen and uses thereof |
| 10/07/2004 | US20040198656 Methods of screening molecules that are used to prevent cardiovascular diseases |
| 10/07/2004 | US20040198655 recombinant human ptx3 gene as a drug target and diagnostic marker for fertility drugs |
| 10/07/2004 | US20040198654 Glucagon-like peptide-1analogs |
| 10/07/2004 | US20040198651 Secreted proteins |
| 10/07/2004 | US20040198649 a VR4 peptide, a VR4 polypeptide modulator, a VR4 polynucleotide, or an antisense agent as analgesics or antiarthritic agents for bone and cartilage disorders; rheumatoid and osteoarthritis, osteoperosis; biodrugs |
| 10/07/2004 | US20040198648 Inhibition of alpha-2 hs glycoprotein (ahsg/fetuin) in obesity and insulin control of glucose homeostasis |
| 10/07/2004 | US20040197917 AXMI-014, delta-endotoxin gene and methods for its use |
| 10/07/2004 | US20040197916 AXMI-004, a delta-endotoxin gene and methods for its use |
| 10/07/2004 | US20040197912 Expression vector comprising nucleotide sequences coding tumor antigens for use in development cancer vaccines; immunotherapeutics |
| 10/07/2004 | US20040197910 Gene regulation in transgenic animals using a transposon-based vector |
| 10/07/2004 | US20040197896 Identifying genes associated with mycobacterial viability and virulence for use in designing modulators for treatment and prevention of infection |
| 10/07/2004 | US20040197895 Packaging lines for generation of high titers or recombinant aav vectors |
| 10/07/2004 | US20040197893 Human double minute proteins (HDM2) for identifying modulator for treatment of cell proliferative disorders |
| 10/07/2004 | US20040197892 Composition binding polypeptides |
| 10/07/2004 | US20040197891 Isolating plasmin, in presence of fibrinogen, from blood or bodily fluids by contacting mixture with chromatographic support comprised of rigidily fixed tranexamic acid or 4-aminomethylbicyclo-[2.2.2.]-octane-1-carboxylic acid |
| 10/07/2004 | US20040197876 Recombinant fusion proteins and the trimers thereof |
| 10/07/2004 | US20040197875 in which the B-domain is partially or completely deleted and may be replaced by a DNA linker segment; for use in human gene therapy |
| 10/07/2004 | US20040197874 Human cytokine polypeptide |
| 10/07/2004 | US20040197873 for drug screening using immunoassays/solid phase synthesis; genetic engineering |
| 10/07/2004 | US20040197872 can be used in single or dual purpose and porcine reproductive respiratory syndrome virus vector vaccines; genetic engineering |
| 10/07/2004 | US20040197871 for diagnosing and treating inflammatory bowel disease using purified polypeptide; genetic engineering |
| 10/07/2004 | US20040197870 for drug screening anticancer/tumor agents using genetically engineered host cells |
| 10/07/2004 | US20040197869 including siderophore receptor polypeptides and porins from gram negative microbes, and preferably, lipopolysaccarhide at a concentration of no greater than about 10.0 endotoxin units per milliliter |
| 10/07/2004 | US20040197867 promotes proteoglycan synthesis; used to induce bone formation in vivo; genetic engineering |
| 10/07/2004 | US20040197865 for detecting agonists of toll-like receptors/immune response modifier drugs genetic engineering |
| 10/07/2004 | US20040197864 Derivatives of magainin and methods of production thereof |
| 10/07/2004 | US20040197863 for use as anticancer/tumor agents using real-time polymerase chain reaction genetic engineering |
| 10/07/2004 | US20040197862 useful in identifying antigen-specific T cells, regulating an immune response and treating subjects suffering from an immune disorder; genetic engineering |
| 10/07/2004 | US20040197861 receptor-based gene expression modulation system for drug screening; genetic engineering |
| 10/07/2004 | US20040197859 useful for treatment of migraine headaches/prophylaxis, menopausal hot flashes, chronic tension type headache, cluster headache, neurogenic or chronic inflammation, gastrointestinal disorders, type 2 diabetes and cardiovascular disorders |
| 10/07/2004 | US20040197857 plasmid is constructed so as to express a fused protein of a sugar chain-binding protein domain with a desired protein |
| 10/07/2004 | US20040197856 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 10/07/2004 | US20040197853 largely reduced of antigenicity compared to native trichosanthin (TCS), while retaining anti-tumor, anti-virus, abortifacient, and ribosome-inactivating protein activities; for treating leukemia |
| 10/07/2004 | US20040197852 Method of preparing peptide fragment having cell death inhibitory activity |
| 10/07/2004 | US20040197844 Marker for inflammatory conditions |
| 10/07/2004 | US20040197840 Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor |
| 10/07/2004 | US20040197830 Diagnostic assay for human matrix Gla-protein and its use as a biomarker |
| 10/07/2004 | US20040197827 Contacting with Ewing sarcoma protein and nuclear receptor; determining binding and changes in ligand-induced activity; use in diagnosis and treatment |
| 10/07/2004 | US20040197825 Methods and compositions for treating urological disorders using 44390, 54181, 211, 5687, 884, 1405, 636, 4421, 5410, 30905, 2045, 16405, 18560, 2047, 33751, 52872, 14063, 20739, 32544, 43239, 44373, 51164, 53010, 16852, 1587, 2207, 22245, 2387, 52908, 69112, 14990, 18547, 115, 579, 15985, 15625, 760, 18603, 2395, 2554, 8675, 32720, 4809, 14303, 16816, 17827, 32620, 577, 619, 1423, 2158, 8263, 15402, 16209, 16386, 21165, 30911, 41897, 1643, 2543, 9626, 13231, 32409, 84260, 2882, 8203, 32678, or 55053 |
| 10/07/2004 | US20040197823 Compositions and methods for aa4rp assay |
| 10/07/2004 | US20040197822 Nueregulin-beta isoforms associated with neuronal processes |
| 10/07/2004 | US20040197818 MinK-related genes, formation of potassium channels and association with cardiac arrhythmia |
| 10/07/2004 | US20040197809 Immunoglobulin fusion for prevention or treatment of viral infection; immunotherapy |
| 10/07/2004 | US20040197808 Comprises nucleotide sequences coding ecdysteroid receptor for identifying modulator for which suppress or prevent insect maturation; insecticidal proteins |
| 10/07/2004 | US20040197799 Determination of a genetic predisposition for behavioral disorders |
| 10/07/2004 | US20040197798 Using alteration in phosphorylation to detect, diagnose, prevent and prognose cell proliferative disorders |
| 10/07/2004 | US20040197786 Method of examining steroid resnponsiveness |
| 10/07/2004 | US20040197783 Comprises nucleotide sequences coding modulator for treatment and prevention of tumor disorders; antisense/antitumor agents; immunotherapy |